Flynn James E Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
67
Insider Buys Sum
$554.93M
Insider Sells Quantity
81
Insider Sells Sum
$226.16M

Insider Activity of Flynn James E

According to the SEC Form 4 filings, Flynn James E, being in a position of

  1. * Director by Deputization at Larimar Therapeutics, Inc.,
    оver the last 12 months, has bought 5000000 shares for $25M, and sold 0 shares,
    over all time since 2016-02-09, has bought 31126511 share for $137.53M, and sold 2682998 shares for $8.89M.

Biography of Flynn James E

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $25,000,0001100
Sells
 $000

Comparison of Insiders on Amount of Buys and Sells

2026-02-27PurchaseLarimar Therapeutics, Inc.
LRMR
* Director by Deputization
5M
5.5007%
$5.00$25M-27.12%
2025-07-31PurchaseLarimar Therapeutics, Inc.
LRMR
* Director by Deputization
9.38M
13.5418%
$3.20$30M+10.69%
2025-06-27SaleARS Pharmaceuticals, Inc.
SPRY
10 percent owner
370,074
0.3822%
$18.46$6.83M-46.29%
2024-11-12SaleARS Pharmaceuticals, Inc.
SPRY
10 percent owner
34,814
0.0432%
$17.49$609,064-21.52%
2024-11-11SaleARS Pharmaceuticals, Inc.
SPRY
10 percent owner
528,456
0.6761%
$18.04$9.53M-25.1%
2024-09-17PurchaseBicara Therapeutics Inc. Common Stock
BCAX
Possible Members of 10% Group
35,000
0.045%
$18.00$630,000-51.96%
2024-03-12SaleAdaptHealth Corp.
AHCO
*Possible Member of 10% Group
114,906
0.0832%
$10.70$1.23M-5.49%
2024-03-11SaleAdaptHealth Corp.
AHCO
*Possible Member of 10% Group
182,607
0.1361%
$11.02$2.01M-5.49%
2024-03-08SaleAdaptHealth Corp.
AHCO
*Possible Member of 10% Group
52,487
0.0387%
$10.93$573,652-5.53%
2024-02-16PurchaseLarimar Therapeutics, Inc.
LRMR
* Director by Deputization
4.29M
6.6831%
$8.74$37.5M-41.94%
2022-09-16PurchaseLarimar Therapeutics, Inc.
LRMR
11.11M
49.2054%
$3.15$35M+21.72%
2021-10-26PurchaseXilio Therapeutics, Inc.
XLO
10 percent owner
387,500
1.4134%
$16.00$6.2M-76.08%
2021-07-09SaleMirum Pharmaceuticals, Inc.
MIRM
10 percent owner
198,650
0.6325%
$15.81$3.14M+11.25%
2021-07-07SaleMirum Pharmaceuticals, Inc.
MIRM
10 percent owner
13,674
0.045%
$15.87$216,993+14.33%
2021-07-06SaleMirum Pharmaceuticals, Inc.
MIRM
10 percent owner
98,478
0.322%
$16.20$1.59M+11.07%
2021-07-02SaleMirum Pharmaceuticals, Inc.
MIRM
10 percent owner
21,198
0.0709%
$17.01$360,599+7.82%
2021-06-30PurchaseLarimar Therapeutics, Inc.
LRMR
685,710
3.341%
$8.75$6M-2.39%
2021-05-04PurchaseWerewolf Therapeutics, Inc.
HOWL
10 percent owner
800,000
4.4986%
$16.00$12.8M-12.48%
2021-03-30PurchaseEdgewise Therapeutics, Inc.
EWTX
10 percent owner
1.25M
1.3005%
$16.00$20M-42.5%
2020-07-28PurchaseAnnexon, Inc.
ANNX
10 percent owner
700,000
2.3238%
$17.00$11.9M+33.07%
Total: 104
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.